Colgate Palmolive (CL) EBT (2009 - 2026)

Colgate Palmolive's EBT history runs 18 years deep, the most recent figure standing at $892.0 million for Q1 2026.

• On a quarterly basis, EBT fell 6.4% year-over-year to $892.0 million in Q1 2026; TTM through Mar 2026 was $3.0 billion, a 23.92% decrease from a year earlier, with the FY2025 full-year figure at $3.1 billion, down 22.67% from the prior year.
• EBT advanced to $892.0 million in Q1 2026 per CL's latest filing, from $108.0 million in the prior quarter.
• Across five years, EBT topped out at $1.0 billion in Q2 2024 and bottomed at $108.0 million in Q4 2025.
• The 5-year median for EBT is $953.0 million (2025), against an average of $821.2 million.
• Across the five-year window, EBT surged 648.48% in 2023 and plunged 89.12% in 2025, its largest moves.
• Year by year, EBT stood at $132.0 million in 2022, then jumped by 648.48% to $988.0 million in 2023, then increased by 0.51% to $993.0 million in 2024, then plunged by 89.12% to $108.0 million in 2025, then jumped by 725.93% to $892.0 million in 2026.
• Per Business Quant, the three latest CL EBT figures stand at $892.0 million (Q1 2026), $108.0 million (Q4 2025), and $992.0 million (Q3 2025).